Phenylacetate and benzoate clearance in a hyperammonemic infant on sequential hemodialysis and hemofiltration

Pediatric Nephrology

Volumn 22, Issue 7, 2007, Pages 1062-1065

  Bunchman, Timothy E ^a,d   Barletta, Gina Marie ^a   Winters, John W ^a   Gardner, John J ^a   Crumb, Teri L ^b   McBryde, Kevin D ^c  

^a HELEN DEVOS CHILDREN S HOSPITAL   (United States)

^b SPECTRUM HEALTH   (United States)

^c CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

Hemodialysis; Hemofiltration; Hyperammonemia; Sodium benzoate; Sodium phenylacetate

Indexed keywords

AMMONIA; BENZOIC ACID; CARBON DIOXIDE; NITROGEN; PHENYLACETIC ACID; PHOSPHORUS; POTASSIUM;

ARTICLE; BLOOD FLOW VELOCITY; BRAIN DISEASE; BREATHING RATE; CASE REPORT; DIALYSATE; DRUG BLOOD LEVEL; DRUG CLEARANCE; HEART RATE; HEMODIALYSIS; HEMOFILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERAMMONEMIA; INFANT; INTUBATION; METHYLMALONIC ACIDEMIA; MUSCLE TONE; PRIORITY JOURNAL; REBOUND; RENAL REPLACEMENT THERAPY; SYSTOLIC BLOOD PRESSURE; ULTRAFILTRATION;

AMMONIA; HEMOFILTRATION; HUMANS; HYPERAMMONEMIA; INFANT, NEWBORN; PHENYLACETATES; RENAL DIALYSIS; SODIUM BENZOATE;

EID: 34250023504     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0436-z     Document Type: Article

References (8)

1. Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED (1984) Neurologic outcome in children with inborn errors or urea synthesis: Outcome of urea-cycle enzymopathies. N Engl J Med 310:1500-1505
2. McBryde KD, Kudelka TL, Kershaw DB, Brophy PD, Gardner JJ, Smoyer WE (2004) Clearance of amino acids by hemodialysis in argininosuccinate synthetase deficiency. J Pediatr 144:536-540
3. Picca S, Dionisi-Vici, Abeni D, Pastore A, Rizzo C, Orzalesi M, Sabetta G, Rizzoni G, Bartuli A (2001) Extracorporeal dialysis in neonatal hyperammonemia: Modalities and prognostic indicators. Pediatr Nephrol 16:862-867
4. McBryde KD, Kershaw DB, Bunchman TE, Maxvold NJ, Mottes TA, Kudelka TL, Brophy PD (2006) Renal replacement therapy in the treatment of confirmed or suspected inborn errors of metabolism. J Pediatr 148:770-778
5. Bunchman TE, Maxvold NJ, Brophy PD (2003) Pediatric convective hemofiltration (CVVH): Normocarb® replacement fluid and citrate anticoagulation. Am J Kidney Dis 42:1248-1252
6. Brophy PD, Mottes TA, Kudelka TL, McBryde KD, Gardner JJ, Maxvold NJ, Bunchman TE (2001) AN-69 membrane reactions are pH-dependent and preventable. Am J Kidney Dis 38:173-178
7. Bunchman TE, Maxvold NJ, Barnett J, Hutchings A, Benfield MR (2002) Pediatric hemofiltration: Normocarb® dialysate solution with citrate anticoagulation. Pediatr Nephrol 17:150-154
8. MacArthur RB, Altincatal A, Tuchman M (2004) Pharmacokinetics of sodium phenylacetate and sodium benzoate following intravenous administration as both a bolus and continuous infusion to health adult volunteers. Mol Genet Metab 81(Suppl 1):S26-S73